Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue
Lili Wu(Sun Yat-sen University), Zhiliang Gao(Sun Yat-sen University)
Cited by 3
Related Papers
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
|Clinical Gastroenterology and Hepatology|2019|111
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0
|Clinical and Molecular Hepatology|2025|21